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Abstract
Background—HFE mutations are associ-
ated with hereditary haemochromatosis.
However, a simple method capable of
demonstrating the cis/trans arrangement
of alleles is lacking, and linkage disequi-
librium between HFE alleles and classic
HLA loci is unknown. These are impor-
tant issues as the pathogenic role of the
mutations is not known.
Aims—To develop a simple method of
genotyping HFE mutations suitable for
clinical use in addition to large disease
studies.
Patients—A total of 330 Caucasoid cadav-
eric organ donor controls were examined.
Ten individuals previously HLA-H geno-
typed by polymerase chain reaction using
restriction fragment length polymor-
phism (PCR-RFLP) were also examined
to validate the method.
Methods—A simple polymerase chain re-
action using sequence speciﬁc primers
(PCR-SSP) capable of haplotyping the
mutations was developed. HFE allele and
haplotype frequencies and linkage dis-
equilibrium with eight HLA class I and II
loci were examined in the control popula-
tion.
Results—27% and 19.7% of patients were
positive for the 63D and 282Y alleles,
respectively.No chromosome carried both
63D and 282Y. Linkage disequilibrium
between 282Y and HLA-A*03 was con-
ﬁrmed, but was not straightforward: some
A*03-associated alleles (DRB1*15,
DQB1*06), but not all (B*07, Cw*0702),
were associated with 282Y.
Conclusions—Linkage disequilibrium
data suggest that an HLA-B*07 contain-
ing haplotype contains an element aVord-
ing protection from haemochromatosis
and may suggest the timing of the founder
282Y mutation.
(Gut 1998;42:566–569)
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The cloning of a novel human leucocyte
antigen (HLA) class I like gene, HFE,
1* has
generated considerable interest. Mutations in
this gene have been associated with hereditary
haemochromatosis
145 and porphyria cutanea
tarda.
6 A single nucleotide change at codon
282 results in an amino acid substitution, Cys
® Tyr (282Y
2†). Homozygosity for 282Y is
present in 90% of patients with haemochroma-
tosis, whereas approximately 10% of controls
have been found to be heterozygous.
145Many
haemochromatosis patients heterozygous for
282Y are also heterozygous for a second poly-
morphism at codon 63, His ® Asp (63D)
which is also present in approximately 25% of
healthy controls.
15It is unclear whether these
282Y and 63D cause haemochromatosis di-
rectly or via linkage to another mutation.
Formal proof of a causal role of these
mutations in haemochromatosis awaits investi-
gation of the role of HFE in iron metabolism.
Several additional aspects of HFE polymor-
phism require further investigation. Haemo-
chromatosis has long been known to be associ-
ated with HLA-A*03 as part of an extended
HLA haplotype,
7 and reports thus far have
conﬁrmed the expected linkage disequilibrium
between 282Y and HLA-A*03.However,there
are limited data concerning the frequency of
the HFE alleles in UK Caucasoids,and no data
concerning linkage disequilibrium between
these alleles and class I and II HLA genes in
control populations. Whilst associations be-
tween the 282Y and 63D and haemochromato-
sis have been detected,
145it is unclear whether
the mutations directly induce disease or act via
an association with hitherto unrecognised loci.
It therefore remains of considerable interest to
examine linkage disequilibrium between the
HFE mutations and other HLA genes. For this
reason we have examined associations between
the HFE mutations and eight classic HLA class
I and II loci in 330 UK Caucasoid controls.
Furthermore, there appears to be an inter-
play between alleles at the two HFE polymor-
phisms. For example, heterozygosity for both
282Y and 63D (compound heterozygosity)
appears to confer susceptibility to
haemochromatosis,
18 but it is important to
determine whether this synergism occurs when
the two mutations are present on the same (cis)
*There is confusion regarding this nomenclature. The
term “HLA-H” was ﬁrst used by Feder et al,
1 but was
previously used to denote a distinct HLA class I-like
pseudogene unrelated to haemochromatosis.
2 It has
thus been recommended that the name of the gene
under discussion revert to “HFE”, the name assigned
by the Genome Database Nomenclature Committee to
the haemochromatosis locus.
3
† The currently accepted nomenclature for the codon
63 His(Asp (‘H63D’) and 282 Cys(Tyr (‘C282Y’)
mutations results in confusion when haplotypes are
described. Thus in this paper, alleles are referred to by
the codon number followed by the amino acid variant
(63H, 63D, 282C and 282Y); haplotypes are denoted
by each codon number followed by the amino acid
allele, e.g. a haplotype of His at codon 63 andTyr at
codon 282 is denoted as ‘63H-282Y’.
Gut 1998;42:566–569 566
Transplantation
Immunology, NuYeld
Department of
Surgery, Churchill
Hospital, Headington,
Oxford OX3 7LJ, UK
C G Mullighan
M Bunce
G C Fanning
S E Marshall
K I Welsh
Correspondence to:
Dr Mullighan.
Accepted for publication
31 October 1997
  group.bmj.com  on October 16, 2011 - Published by  gut.bmj.com Downloaded from or opposite (trans) chromosomes.The observa-
tion that no 282Y homozygotes also carry the
63D mutation suggests that no chromosome
carries both mutations and that the mutations
are always in trans in compound
heterozygotes.
89However, without recourse to
family studies, existing HFE genotyping tech-
niques are incapable of formally demonstrating
cis/trans orientation of codon 63 and 282
alleles. Current genotyping techniques require
the use of restriction enzymes or labelled oligo-
nucleotide primers or probes.
145These tech-
niques involve several steps, are time consum-
ing and expensive, and often pose
interpretative diYculty. Consequently we have
developed a rapid, simple and reliable one step
HFE genotyping technique using the polymer-
ase chain reaction and sequence speciﬁc prim-
ers (PCR-SSP). Not only does this method
identify alleles at each polymorphism, it also
formally demonstrates haplotypes (combina-
tions of alleles at codons 63 and 282 present on
the same chromosome).
Methods
PRIMER DESIGN
Sense primers speciﬁc for the codon 63
polymorphism were combined with antisense
primers speciﬁc for codon 282 to amplify all
four possible HFE haplotypes: 63H–282C,
63H–282Y, 63D–282C, and 63D–282Y (table
1). Control primers speciﬁc for the human
growth hormone (HGH) gene were used to
verify successful ampliﬁcation in each
reaction.
10
DNA EXTRACTION
Genomic DNA was extracted from EDTA or
tri-sodium citrate anticoagulated peripheral
blood by a salting out method.
11 The buVy coat
from 5 ml of anticoagulated blood was lysed in
a red cell lysis buVer (RCLB) consisting of
0.144 M NH4Cl and 1 mM NaHCO3. After
centrifugation the pellet was rinsed in RCLB
and resuspended in 3 ml nuclear lysis buVer
(0.4 M NaCl, 2 mM Na2EDTA, 10 mM Tris-
HCl) and 200 µl of 10% (w/v SDS) in water.
After vigorous mixing 1 ml of 6 M NaCl and
3 ml of chloroform were added, vortexed, and
centrifuged at 3000 rpm for 30 minutes. DNA
aspirated from the top aqueous phase was pre-
cipitated with 95% ethanol, washed in 70%
ethanol, and resuspended in distilled water.
AMPLIFICATION CONDITIONS
Reaction mixtures of 13 µl were used, consist-
ing of 67 mM Tris base pH 8.8, 16.6 mM
ammonium sulphate, 2 mM magnesium chlo-
ride, 0.01% (v/v) Tween 20, 200 mM each of
dATP, dTTP, dGTP and dCTP, HFE forward
and reverse primers at 6.8 µM each, HGH
control primers at 0.68 µM, between 0.1 and
0.01 µg DNA and 0.1875 units of Taq
polymerase (Advanced Biotechnology, Lon-
don, UK). Reaction mixtures were dispensed
under 10 µl of mineral oil (Sigma, UK) in
96-well PCR plates (Costar, High Wycombe,
UK).
DNA samples were ampliﬁed in GeneAmp
PCR system 9600 (Perkin-Elmer Corporation)
or in MJ Research PTC-200 thermal cyclers
with cycling parameters as follows: one minute
at 96°C followed by ﬁve cycles of 96°C for
25 seconds, 70°C for 45 seconds, and 72°C for
45 seconds, followed by 21 cycles of 96°C for
25 seconds, 65°C for 50 seconds, and 72°C for
45 seconds, followed by four cycles of 96°C for
25 seconds, 55°C for 60 seconds, and 72°C for
120 seconds. PCR plates were sealed with
Thermowell sealers (Costar) and dipped in
mineral oil to improve plate to block contact.
GEL ELECTROPHORESIS AND PRODUCT DETECTION
Following PCR, 5 µl of loading buVer consist-
ing of 0.25% Orange G, 30% v/v glycerol, and
0.5´ TBE buVer (89 mM Tris base, 89 mM
boric acid,2 mM EDTA,pH 8.0) was added to
Table 1 Details of reaction mixtures used for HFE genotyping
Reaction
number
Sense
primer
number Sense primer sequence (5'–3')
Nucleotide
position
Antisense
primer
number Antisense primer sequence (5'–3')
Nucleotide
position Speciﬁcity
Product
size (bp)
1 805 AGCTGTTCGTGTTCTATGATC 388–408 807 CTGGGTGCTCCACCTGGC 1066–1083 63H–282C 1460
2 805 AGCTGTTCGTGTTCTATGATC 388–408 808 CTGGGTGCTCCACCTGGT 1066–1083 63H–282Y 1460
3 806 AGCTGTTCGTGTTCTATGATG 388–408 807 CTGGGTGCTCCACCTGGC 1066–1083 63D–282C 1460
4 806 AGCTGTTCGTGTTCTATGATG 388–408 808 CTGGGTGCTCCACCTGGT 1066–1083 63D–282Y 1460
5 805 AGCTGTTCGTGTTCTATGATC 388–408 835 CTGTGGTTGTGATTTTCCATAA 535–566 63H 178
6 806 AGCTGTTCGTGTTCTATGATG 388–408 835 CTGTGGTTGTGATTTTCCATAA 535–566 63D 178
7 834 TTGGTGAAGGTGACACATCAT 846–866 807 CTGGGTGCTCCACCTGGC 1066–1083 282C 237
8 834 TTGGTGAAGGTGACACATCAT 846–866 808 CTGGGTGCTCCACCTGGT 1066–1083 282Y 237
Control primers (reactions 1–4)
725 GCCTTCCCAACCATTCCCTT 726 TCACGGATTTCTGTTGTGTTTC HGH control 425
Speciﬁcity of primers is determined by the underlined 3' nucleotide. Primers 834 and 835 are consensus, non-allele speciﬁc primers. Nucleotides are numbered
according to Feder et al
1 (Genbank accession number U60319). The genomic sequence of HFE has not been published, but from the known sequence of HLA-A,
codons 63 and 282 would lie in exons 2 and 4, respectively, separated by about 1460 nucleotides. Examples of reactions 1–4 only are given in ﬁg 1.
Figure 1 Examples of HFE genotyping.PCR products
have been electrophoresed in ethidium bromide impregnated
1% agarose gels prior to UV illumination.The direction of
electrophoresis is upwards.Each lane has an (uppermost)
425 bp control PCR product,with or without a (lower)
HFE haplotype speciﬁc product of approximately 1460 bp.
Lanes 1–4:haemochromatosis patient;positive lane 2,
63H–282Y homozygous.Lane 5:DNA ladder.Lanes 6–9:
control sample;positive lanes 7 and 8;63H–282Y and
63D–282C heterozygous (compound heterozygote).
Rapid method of haplotyping HFE mutations 567
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were then electrophoresed in 1.0% agarose gels
containing 0.5 µg/ml ethidium bromide for
20–25 minutes at 15 V/cm in 0.5´ TBE buffer,
visualised with UV illumination and photo-
graphed with a Polaroid land camera. Exam-
ples of a compound heterozygote and a 282Y
homozygote are shown in ﬁg 1.
VALIDATION
A second PCR-SSP approach was used to
exclude false positive or false negative ampliﬁ-
cation. Allele speciﬁc primers for each poly-
morphism were used in conjunction with non-
allele speciﬁc primers for four supplementary
reactions (table 1, reactions 5–8). These
reactions identiﬁed alleles at each polymor-
phism, but not haplotypes. Absolute concord-
ance between the two methods was obtained
for codon 63 and 282 genotypes in all samples.
To validate further the method for codon
282 alleles, 10 patients with suspected haemo-
chromatosis previously genotyped for codon
282 by polymerase chain reaction using
restriction fragment length polymorphism
(PCR-RFLP) were also examined.
CONTROL SELECTION
A total of 330 UK Caucasoid cadaveric renal
allograft donors were used as a control popula-
tion. HLA-A, -B, -Cw, -DRB1, -DRB3–5, and
-DQB1 genotyping was performed for all con-
trols as previously described.
10
DATA ANALYSIS AND STATISTICS
Mutation frequencies were determined in three
ways:as phenotype frequencies (the proportion
of controls positive for a mutation), allele
frequencies (proportion of positive chromo-
somes, determined by direct counting), and
gene frequencies.Gene frequencies were calcu-
lated using equation 1 where p = gene
frequency and f = allele frequency:
p =1 − Ö 1−f (1)
Alleles at each polymorphism were said to be
in Hardy-Weinberg equilibrium if the observed
homozygote and heterozygote frequencies did
not diVer signiﬁcantly (p>0.05) from those
expected when analysed by the ÷
2 test. Linkage
disequilibrium between HFE alleles and HLA
class I and II alleles was initially assessed by ÷
2
analysis of 2 ´ 2 contingency tables. Probable
haplotypes thus identiﬁed were directly
counted and the resulting haplotype frequen-
cies used to calculate Äs, a measure of the dif-
ference between observed and expected haplo-
type frequencies (equation 2; Pab = observed
frequency of haplotype ab and Pa and Pb = fre-
quencies of alleles a and b):
Äs = Ä
Ä max
= Pab −( P a´P b)
P a(1 − Pb) (2)
Linkage disequilibrium data are also repre-
sented using the correlation coeYcient r,
calculated using equation 3 where n = number
of observations:
r=Ö
÷
2
n (3)
Results
Control phenotype, allele, and gene frequen-
cies are listed in table 2. Comparison of
observed and expected genotype frequencies
(table 3) demonstrated that codon 63 and 282
alleles were in Hardy-Weinberg equilibrium;
19.7% of controls carried 282Y. One control
was 282Y homozygous and 11 were compound
heterozygotes. Iron overload was not evident at
autopsy in any of these individuals, although
this was not formally excluded by serum iron
studies and liver biopsy. Furthermore, it was
directly shown that 63D and 282Y were in trans
in all 11 compound heterozygotes.
Codon 282 genotype was identical by both
PCR-SSP and PCR-RFLP in the 10 patients
genotyped by both methods (nine patients
Table 2 HLA-HFE phenotype,allele and gene frequencies in 330 UK white controls
Allele
Phenotype count
(n=330) Phenotype frequency Allele count (n=660) Allele frequency Gene frequency
63H 326 0.99 568 0.86 0.63
63D 89 0.27 92 0.14 0.07
282C 329 1.00 594 0.90 0.68
282Y 65 0.20 66 0.10 0.05
Table 3 HFE genotype and haplotype frequencies in 330 controls
Observed Expected
Genotype Number (total = 330) Frequency Number Frequency Hardy-Weinberg ÷
2
(p)
Codon 63 63HH 241 0.73 244 0.74
63HD 85 0.26 80 0.24 0.57 (0.75)
63DD 4 0.01 6 0.02
Codon 282 282CC 265 0.80 267 0.81
282CY 64 0.19 59 0.18 1.21 (0.55)
282YY 1 0.003 3 0.01
Haplotype Number (total = 330) Frequency
Codons 63–282 63H–282C 314 0.95
63D–282C 89 0.27
63H–282Y 65 0.20
63D–282Y 0 0
Compound heterozygotes
(63H–282Y and
63D–282C)
11 0.033
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erozygous).
Linkage disequilibrium data for 282Y and
63D with HLA class I and II alleles are
presented in table 4. The expected linkage dis-
equilibrium between 282Y and HLA-A*03
was conﬁrmed (p<0.0001). Linkage disequi-
librium was also observed between 282Y and
some (DRB1*15,p = 0.009,and DQB1*0602,
p = 0.006), but not all (HLA-B*07 and HLA-
Cw*0702), HLA-A*03 associated alleles. 63D
was in linkage disequilibrium with HLA-A*29
(p = 0.006). This has not previously been
documented.
Discussion
We have developed a rapid and simple method
of identifying alleles at the two known HFE
polymorphisms,and of formally demonstrating
the cis/trans orientation of alleles.Cumbersome
restriction enzyme use and interpretation is
avoided, and one person with one thermal
cycler can comfortably genotype more than
100 samples per day. Reaction conditions are
identical to those used for routine HLA class I
and II genotyping,
10 so this method can easily
be incorporated into HLA typing protocols for
patients with suspected haemochromatosis.
The frequency of 282Y heterozygosity in the
control population was 19.4%. Although
higher than in previous reports,
11 2the 282Y
allele frequency (10%) is similar to that
detected in other Caucasoid populations.
12 The
observed allele and genotype frequencies are
unlikely to be erroneous as a second method
was used to conﬁrm the genotype in every
sample, and alleles were in Hardy-Weinberg
equilibrium. Furthermore, the method has
been validated by genotyping 10 samples
previously typed by PCR-RFLP, with absolute
concordance between the two methods. The
representative nature of this control population
is reinforced by the ﬁnding of the expected
HLA class I and II control frequencies
(particularly HLA-A*03 (28.4%), with which
282Y is associated). Whilst the 282Y rate of
19.4% reduces the relative risk for haemochro-
matosis in individuals carrying 282Y, this poly-
morphism remains a strong risk factor.
Twelve controls were either 282Y homozy-
gotes or compound heterozygotes. Although
none had evidence of iron overload at autopsy,
it is possible that features of iron overload
would have developed with time.
The expected linkage disequilibrium be-
tween 282Y and HLA-A*03 was observed, but
this association was not entirely straightfor-
ward. Although HLA-A*03 was in linkage dis-
equilibrium with HLA-B*07, -Cw*0702,
-DRB1*15, and -DQB1*0602 in the control
population, 282Y was only associated with
A*03, DRB1*15, and DQB1*0602. HLA-
B*07 and -Cw*0702 are also in linkage
disequilibrium with other HLA-A alleles such
as A*02. We speculate that another haplotype
containing HLA-B*07 and -Cw*0702 contains
an element aVording protection against
haemochromatosis. The presence of 282Y on
the A*03-B*07-Cw*0702 haplotype, but not
other B*07 haplotypes, may suggest the timing
of the original “founder” 282Y mutation. This
hypothesis will require testing in further
studies.
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Table 4 Linkage disequilibrium between HFE and HLA class I and II alleles
Haplotype Haplotype count
Haplotype
frequency ÷
2 ÷
2 p Äsr
282Y–A*03 33 0.05 15.86 <0.0001 0.41 0.22
282Y–B*07 26 0.04 0.91 NS 0.26 0.05
282Y–C*0702 27 0.04 1.39 NS 0.27 0.06
282Y–DRB1*15 33 0.05 5.69 0.009 0.39 0.13
282Y–DQB1*0602 32 0.05 6.4 0.006 0.38 0.14
63D–A*29 13 0.02 6.38 0.006 0.11 0.14
Haplotype counts were obtained by counting the number of controls positive for both alleles on a haplotype. Haplotype frequencies
were calculated by dividing the number of counted haplotypes by the total number of chromosomes studied (660). Haplotypes are
listed as combinations of 282Y or 63D with class I or II alleles for convenience; however, data are identical for haplotypes listed as
63–282–class I/II combinations. This is because 282Y is only found with 63H and 63D with 282C—for example, the 282Y–A*03
date are identical to 63H–282Y–A*03 data. 63H and 282C are not in linkage disequilibrium with class I or II alleles because of the
high frequencies of these alleles.
Äs, Ä standardised; r, correlation coeYcient (for deviation, see text).
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